SB 878 was amended and passed the Senate on March 23. The bill expands pharmacist scope authority for CLIA-waived tests and allows prescribing of certain types of medical equipment. It also enhances the Board of Pharmacy’s authority to allow pharmacies to dispense medications during a declared emergency. In addition, it would allow the over-the-counter sale of ivermectin and hydroxychloroquine, with a warning label, once the FDA authorizes them for over-the-counter dispensing. The bill was sent the House of Representatives for further action.
For more information, contact NACDS’ Mary Staples at 817-442-1155.